Barry S. Ticho
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Stoke Therapeutics, Inc. (STOK)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Stoke Therapeutics, Inc. (STOK) | M.D., Ph.D., FACC Chief Medical Officer | $514,030 | $2,469,437 |
| 2023 | Stoke Therapeutics, Inc. (STOK) | M.D., Ph.D., FACC Chief Medical Officer | $494,259 | $1,648,007 |
| 2022 | Stoke Therapeutics, Inc. (STOK) | M.D., Ph.D., FACC Chief Medical Officer | $470,723 | $2,386,257 |
| 2021 | Stoke Therapeutics, Inc. (STOK) | M.D., Ph.D., FACC Chief Medical Officer | $448,308 | $3,149,491 |
| 2020 | Stoke Therapeutics, Inc. (STOK) | M.D., Ph.D., FACC Chief Medical Officer | $428,800 | $1,877,496 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.